Phase 2 CAD Clinical Trials
9 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–9 of 9 trials
Recruiting
Phase 2
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
Peripheral Arterial DiseaseCoronary Artery Disease (CAD)
Sirius Therapeutics Co., Ltd.104 enrolled1 locationNCT07318155
Recruiting
Phase 2
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Heart DiseaseInflammationCoronary Arterial Disease (CAD)+3 more
Abcentra240 enrolled41 locationsNCT06927739
Recruiting
Phase 2
The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels
Cadmium Exceeds the Standard
Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.11 enrolled1 locationNCT07057414
Recruiting
Phase 2
Study of Sivelestat Sodium in OPCABG
Coronary Heart DiseaseCoronary Artery DiseaseCoronary Arterial Disease (CAD)
Affiliated Hospital of Nantong University62 enrolled1 locationNCT07118930
Recruiting
Phase 2
Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer
Triple-Negative Breast CancerCadonilimab
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology27 enrolled1 locationNCT06367088
Recruiting
Phase 2
NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC
Advanced CancerPancreatic AdenocarcinomaCapecitabine+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT06405490
Recruiting
Phase 2
Colchicine Use in Intracranial Atherosclerotic Disease
ICAD - Intracranial Atherosclerotic Disease
Chinese University of Hong Kong72 enrolled1 locationNCT05503225
Recruiting
Phase 2
Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma
Cadonilimab and Lenvatinib
Peking Union Medical College Hospital30 enrolled1 locationNCT06215651
Recruiting
Phase 2
Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer
Metastatic Colorectal CancerRAS MutationCadonilimab+1 more
Fudan University53 enrolled1 locationNCT06218810